UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported) – May 4, 2010

 

 

WEST PHARMACEUTICAL SERVICES, INC.

(Exact name of registrant as specified in its charter)

 

 

Pennsylvania

 

1-8036

 

23-1210010

(State or other jurisdiction
of Incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

 

101 Gordon Drive, PO Box 645,
Lionville, PA

 

19341-0645

(Address of principal executive offices)

 

(Zip Code)

 

(610) 594-2900

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

West Pharmaceutical Services, Inc. held its annual meeting of shareholders on May 4, 2010, and the following matters were voted on at that meeting:

 

1.             The election of the following Class II directors, who will serve for a term of three years and until their successors are elected and qualified:

 

Name

 

For

 

Withheld

 

Thomas W. Hofmann

 

26,283,870

 

472,346

 

L. Robert Johnson

 

26,059,278

 

696,938

 

John P. Neafsey

 

26,056,928

 

699,288

 

Geoffrey F. Worden

 

26,059,513

 

696,704

 

 

2.             The ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2010 fiscal year was approved by the following vote: For, 29,186,931; Against, 41,997; Abstain, 6,590; Broker Non-Vote,  -0-.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

WEST PHARMACEUTICAL SERVICES, INC.

 

 

 

 

 

 

/s/ John R. Gailey III

 

 

John R. Gailey III, Vice President, General

 

 

Counsel and Secretary

 

 

May 10, 2010

 

3